Former Pfizer CEO Kindler joins Lux Capital

Thu Aug 9, 2012 6:27am IST

Stocks

   

Aug 8 (Reuters) - Jeff Kindler, the former chief executive of Pfizer Inc, has joined venture capital firm Lux Capital as a partner, Lux said in a statement, where he will help scout for healthcare investment opportunities and work with portfolio companies.

Kindler retired from Pfizer in December 2010 after eight years with the company and was replaced as CEO by Ian Read.

Apart from his new role at Lux Capital, Kindler also serves on the board of several other pharmaceutical and healthcare companies. He is also a member of U.S. President Barack Obama's management advisory board and a director at private equity firm Starboard Capital Partners.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Sino-Indian Ties

REUTERS SHOWCASE

India-China Relations

India-China Relations

India and China look to put knotty relations on new footing.  Full Article 

Importing Iron Ore

Importing Iron Ore

As mining curbs bite, India offers market to glut-hit iron ore.  Full Article 

Lower Output

Lower Output

IOC cuts refinery output as rains hit fuel demand - source.  Full Article 

Drug Approval

Drug Approval

Epirus, Ranbaxy win India approval for arthritis drug copy.  Full Article 

Farming and Technology

Farming and Technology

Climate smart farmers get tech savvy to save India's bread basket.  Full Article 

Rajan Speaks

Rajan Speaks

RBI chief Rajan says limiting reliance on foreign debt.  Full Article 

India-Vietnam Ties

India-Vietnam Ties

India tightens Vietnam defence, oil ties ahead of China Xi's visit.  Full Article 

Debt & Equity Deal

Debt & Equity Deal

KKR to lend $175 million to GMR Infrastructure - source.  Full Article 

Preparing for IPO

Preparing for IPO

Alibaba boosts IPO as demand strengthens.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage